AI Medical Device Company Iris Receives Minister of Economy, Trade and Industry Award at the 10th Monozukuri Nippon Grand Prize

Iris Co., Ltd. (Headquarters: Chiyoda-ku, Tokyo; Representative Director: Sho Okuyama; hereinafter referred to as 'our company') has received the Minister of Economy, Trade and Industry Award at the '10th Monozukuri Nippon Grand Prize' for its initiative in 'Datafication of Pharyngeal Examination through the Development and Promotion of the AI Medical Device 'nodoca'.' In conjunction with this, an award ceremony was held on March 25th at the Prime Minister's Official Residence (Chiyoda-ku). The 'Monozukuri Nippon Grand Prize' is a system where the country recognizes and awards individuals who form the core of manufacturing and production sites, as well as companies that have developed innovative products beyond conventional frameworks, in order to inherit and develop 'Monozukuri' that supports the development of Japan's industry and culture. This time, high evaluation was given for developing and widely delivering a system that diagnoses infectious diseases from throat images and clinical information using AI without requiring sample collection, and for establishing 'New value creation through data utilization' where data circulates and leads to the well-being of patients and healthcare professionals. Medical data used in diagnosis through the AI medical device nodoca is legally and appropriately processed in a privacy-conscious format, and will be utilized for future medical practice through further improvement of the pharyngeal AI algorithm. Information and medical experiences obtained through this product are returned to the quality of medical care in healthcare settings as a 'resource' for society as a whole, creating a cycle that benefits the next patient. Our company will continue to promote the social implementation of advanced technologies, including AI, to respond to changing medical needs and build sustainable medical infrastructure. ■ About nodoca nodoca® is an AI medical device used for influenza diagnosis by analyzing throat images and patient interview information, etc., using AI to detect findings characteristic of influenza. nodoca was developed with the involvement of over 100 domestic medical institutions cumulatively. Furthermore, it was developed through the collaboration of 'Industry, Government, Academia, and Medicine' in medicine and information engineering, including research and development as a 'Japan Society for Emergency Medicine Recommended AI Research,' commercialization support by the New Energy and Industrial Technology Development Organization (NEDO), and the utilization of the domestically produced supercomputer 'ABCI' at the National Institute of Advanced Industrial Science and Technology (AIST). ■ About Iris Founded in 2017 with the mission of 'Creating open healthcare where everyone can co-create.' A large number of professionals are gathered, including Representative Director Sho Okuyama, who is a practicing physician, healthcare professionals, individuals from government bodies such as the Ministry of Health, Labour and Welfare and the Ministry of Economy, Trade and Industry, data scientists specializing in the AI medical field, and professionals from major medical device manufacturers. They are developing AI medical devices that digitize the expert skills of physicians by leveraging deep learning technology (AI technology). [Company Profile] Company Name: Iris Co., Ltd. Representative Director: Sho Okuyama Business Activities: Development, manufacturing, and sales of AI-powered medical devices, and research and development of machine learning technologies. Established: November 2017 Head Office Location: 28-4 Kanda Higashi-Matsushita-cho, Chiyoda-ku, Tokyo 101-0042 Company URL: https://aillis.jp/